Hainan Cancer Hospital
13
6
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers
Role: lead
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
Role: collaborator
Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.
Role: lead
Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
Role: collaborator
SIRT or TACE Plus Lenvatinib and PD-(L)1 Inhibitor in High Burden HCC
Role: collaborator
Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study
Role: collaborator
A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules
Role: collaborator
Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
Role: collaborator
Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis
Role: collaborator
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
Role: collaborator
The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications
Role: collaborator
Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy
Role: collaborator
Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
Role: collaborator
All 13 trials loaded